Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis

Background: Breast cancer (BC) is the leading cause of cancer-related deaths among women worldwide. The application of advanced technology has promoted accurate diagnosis and treatment of cancer. Anhydroicaritin (AHI) is a flavonoid with therapeutic potential in BC treatment. The current study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feifei, Shi, Youyang, Yang, Xiaojuan, Luo, Zhanyang, Zhang, Guangtao, Yu, Kui, Li, Feng, Chen, Lixin, Zhao, Youkang, Xie, Ying, Wu, Yuanyuan, Yang, Jianfeng, Zhou, Xiqiu, Liu, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844201/
https://www.ncbi.nlm.nih.gov/pubmed/35178395
http://dx.doi.org/10.3389/fcell.2021.764481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844201/
https://www.ncbi.nlm.nih.gov/pubmed/35178395
http://dx.doi.org/10.3389/fcell.2021.764481

Ejemplares similares